![](https://c4ip.org/wp-content/uploads/2024/01/Screenshot-2024-01-12-at-10.47.00-AM-300x183.png)
News
![](https://c4ip.org/wp-content/uploads/2024/01/Screenshot-2024-01-12-at-10.47.00-AM-300x183.png)
![](https://c4ip.org/wp-content/uploads/2023/04/WSJ_Logo-300x26.png)
Apple Keeps Chasing the Ultimate Health-Tracking Watch—but It Could Take Years
December 28, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2022/04/IPWatchdog-300x68.png)
The Top U.S. FRAND / RAND Licensing Developments of 2023 Part II: Ghosts of Christmas Past and Christmas Future
December 27, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2022/04/IPWatchdog-300x68.png)
From AI to Amgen, Here’s Everything IP that Mattered in 2023
December 24, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2023/03/New_York_Daily_News_Logo-300x30.png)
Gov. Hochul expected to veto N.Y. ban on noncompete agreements
December 22, 2023
No Comments
Why the Apple Watch is being banned — and how Apple can avoid it
December 19, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2023/12/South_Florida_On_Light@3x-300x57.webp)
![](https://c4ip.org/wp-content/uploads/2023/11/1200px-Bloomberg_Law_Logo.svg-300x98.png)
Biden Drug Patent Seizures Would Test Scope of Government Power
December 8, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2022/04/IPWatchdog-300x68.png)
Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber
December 7, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2022/12/bioworld-logo-300x61.png)
‘Oh when the government goes marching in’ a rising US threat?
December 7, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2023/12/Endpoints-News-logo-300x63.webp)
Biden proposal on ‘march in’ rights would have limited effect on current drug costs, critics say
December 7, 2023
No Comments
![](https://c4ip.org/wp-content/uploads/2021/06/law360-logo-2021-300x74.png)